ESSA Pharma Inc.
EPIXDelisted Oct 9, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001633932
ESSA Pharma Inc. was delisted on Oct 9, 2025; its insiders filed their last Form 4 on Oct 15, 2025; 32 institutions reported holding it in 13F filings for Q3 2025, worth $4.30M in total; no superinvestor held it.
13F holders, Q4 2025
Institutional positions in ESSA Pharma Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
EPIX is no longer listed, and 13F filings after Q3 2025 list far fewer holders. See Q3 2025
- Institutional holders
- 0
- −32 vs. Q3 2025
- Shares held
- 0
- −22.5M (−100.0%) vs. Q3 2025
- Total value
- $0
- −$4.30M (−100.0%) vs. Q3 2025
- New holders
- 0
- 0 more added
- Sold out
- 32
- 0 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EPIX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 32 | $4.30M |
| Q2 2025 | 36 | $52.7M |
| Q1 2025 | 36 | $50.1M |
| Q4 2024 | 45 | $58.8M |
| Q3 2024 | 32 | $212.7M |
| Q2 2024 | 31 | $185.1M |
| Q1 2024 | 33 | $297.5M |
| Q4 2023 | 31 | $229.4M |
| Q3 2023 | 36 | $103.4M |
| Q2 2023 | 39 | $89.8M |
| Q1 2023 | 37 | $98.3M |
| Q4 2022 | 45 | $84.1M |
| Q3 2022 | 54 | $62.2M |
| Q2 2022 | 59 | $119.0M |
| Q1 2022 | 70 | $229.9M |
| Q4 2021 | 60 | $530.1M |
| Q3 2021 | 75 | $297.4M |
| Q2 2021 | 80 | $976.0M |
| Q1 2021 | 70 | $895.7M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding ESSA Pharma Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BVF Inc | 0 | $0 | 0.00% | −11,668,473−100.0% | Sold out |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −4,362,026−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −1,904,061−100.0% | Sold out |
| Pfizer Inc | 0 | $0 | 0.00% | −1,675,000−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −591,834−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −540,984−100.0% | Sold out |
| Shay Capital LLC | 0 | $0 | 0.00% | −536,533−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −336,164−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −214,800−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −144,449−100.0% | Sold out |
| CSS LLC | 0 | $0 | 0.00% | −103,488−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −77,036−100.0% | Sold out |
| Yakira Capital Management, Inc. | 0 | $0 | 0.00% | −72,123−100.0% | Sold out |
| Magnus Financial Group LLC | 0 | $0 | 0.00% | −55,206−100.0% | Sold out |
| Skandinaviska Enskilda Banken AB (publ) | 0 | $0 | 0.00% | −51,973−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −45,524−100.0% | Sold out |
| Beaumont Capital Management, LLC | 0 | $0 | 0.00% | −28,225−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −23,840−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −19,831−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −20,381−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −15,201−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −9,800−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −6,000−100.0% | Sold out |
| BlackRock, Inc. | 0 | $0 | 0.00% | −7,074−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −5,473−100.0% | Sold out |
| CIBC Private Wealth Group, LLC | 0 | $0 | 0.00% | −2,500−100.0% | Sold out |
| Federation des caisses Desjardins du Quebec | 0 | $0 | 0.00% | −2,050−100.0% | Sold out |
| TD Waterhouse Canada Inc. | 0 | $0 | 0.00% | −900−100.0% | Sold out |
| Truvestments Capital LLC | 0 | $0 | 0.00% | −490−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −355−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −21−100.0% | Sold out |
| SBI Securities Co., Ltd. | 0 | $0 | 0.00% | −16−100.0% | Sold out |